7 citations · 10 across the 2 of their papers we have counts for
Showing stat.APShow all
2 papers · 1 filter
stat.AP2022★ 7 cited
Designing an exploratory phase 2b platform trial in NASH with correlated, co-primary binary endpoints
Elias Laurin Meyer, Peter Mesenbrink, Nicholas A. Di Prospero +5
Non-alcoholic steatohepatitis (NASH) is the progressive form of nonalcoholic fatty liver disease (NAFLD) and a disease with high unmet medical need. Platform trials provide great b…
stat.AP2022★ 3 cited
CohortPlat: Simulation of cohort platform trials investigating combination therapies
Elias Laurin Meyer, Peter Mesenbrink, Cornelia Dunger-Baldauf +2
Platform trials have gained a lot of attention recently as a possible remedy for time-consuming classical two-arm randomized controlled trials, especially in early phase drug devel…